28
Nov
In line with President Nana Akufo-Addo's vision to make Ghana a domestic hub for vaccine production in response to the COVID-19 pandemic and to prevent any kind of pandemic or viral diseases, DEK Vaccines Limited has launched a bankable feasibility study (BFS) and vaccine project for this vision to come into fruition. DEK Vaccines Limited is a partnership of some pharmaceuticals companies in Ghana spearheading this vaccine project. The company estimates to begin production by the fourth quarter of the year 2024, however feasibility tests and preparations for the establishment of a vaccine (fill and finish) facility have already started with…